Cartesian Therapeutics (RNAC) Exchange Rate Effect (2015 - 2026)
Cartesian Therapeutics (RNAC) posted quarterly Exchange Rate Effect of -$7000.0 for Q1 2026, down 121.88% year-over-year from $32000.0 in Q1 2025, and down 163.64% quarter-over-quarter from $11000.0 in Q4 2025.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Exchange Rate Effect (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Exchange Rate Effect for 12 consecutive years, with -$7000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 121.88% year-over-year to -$7000.0; the TTM figure through Mar 2026 stood at $6000.0 (down 62.5% YoY), while the FY2025 annual figure was $45000.0, up 314.29% from the prior year.
- Exchange Rate Effect eased to -$7000.0 in Q1 2026 per RNAC's latest filing, from $11000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $115000.0 in Q2 2022 and bottomed at -$45000.0 in Q4 2022.
- Historically, Exchange Rate Effect has averaged -$941.18 across 5 years, with a median of -$10000.0 in 2025.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect plunged 650.0% — and 2025, when it surged 740.0%.
- Cartesian Therapeutics' Exchange Rate Effect stood at -$45000.0 in 2022, then surged by 135.56% to $16000.0 in 2023, then tumbled by 193.75% to -$15000.0 in 2024, then surged by 173.33% to $11000.0 in 2025, then sank by 163.64% to -$7000.0 in 2026.
- Business Quant data shows RNAC's Exchange Rate Effect at -$7000.0 in Q1 2026, $11000.0 in Q4 2025, and -$10000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Cartesian Therapeutics | 271.98 Mn | 271.98 Mn | - | -25,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25,000.00 |
| Mar 31, 2026 | -7,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | -15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | -20,000.00 |
| Jun 30, 2023 | -28,000.00 |
| Mar 31, 2023 | -21,000.00 |
| Dec 31, 2022 | -45,000.00 |
| Sep 30, 2022 | -21,000.00 |
| Jun 30, 2022 | 115,000.00 |
| Mar 31, 2022 | -29,000.00 |
| Dec 31, 2021 | -6,000.00 |
| Sep 30, 2021 | -6,000.00 |